Prevalence of obesity and cardiovascular risk factors in a group of paediatric patients with type 1 diabetes;Prevalencia de obesidad y de factores de riesgo cardiovascular en una población de pacientes pediátricos con diabetes tipo 1

Anales de Pediatria

Volumn 78, Issue 6, 2013, Pages 382-388

  Palomo Atancea, E ^a   Giralt Muinaa, P ^a   Ballester Herreraa, M J ^a   Ruiz Canob, R ^b   Leon Martinc A ^a   Giralt Muina, J ^c  

^a HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Insulin resistance; Metabolic syndrome; Obesity; Prevalence; Type 1 diabetes

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PEDIATRICS; PREVALENCE; WAIST CIRCUMFERENCE; CARDIOVASCULAR DISEASES; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES COMPLICATIONS; FEMALE; MALE; OVERWEIGHT; PROSPECTIVE STUDY; RISK FACTOR; CARDIOVASCULAR DISEASE; DIABETES MELLITUS;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY; OVERWEIGHT; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84898181771     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2012.11.011     Document Type: Article

References (40)

1. WHO. Overweight and obesity. (Sitio web). Geneva, Switzerland: World Health Organization, 2006 [consultado 11 Jun 2012]. Disponible en: http://www.who.int/mediacentre/ factsheets/fs311/en/index/html
2. Martos-Moreno GA, Argente J. Obesidades pediátricas: de la lactancia a la adolescencia. An Pediatr (Barc). 2011;75:63, e1-23
3. Lobstein T, Baur L, Uauy R, for the IOTF Childhood Obesity Working Group. Obesity in children and young people. A crisis in public health. Obes Rev. 2004;5S:4-85
4. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. Diabetes Care. 2007;30:707-12
5. Chillarón JJ, Goday A, Botet JP. Síndrome metabólico, diabetes mellitus tipo 1 y resistencia a la insulina. Med Clin (Barc). 2008;130:466-71
6. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: The Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes. 2006;55:1463-9
7. National High Blood Pressure Education Program Working Group on High Blood Presure in Children, Adolescents. The Fourth Report on the Diagnosis. Evaluation and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004;114:555-76
8. Guía de Práctica Clínica sobre la Prevención y el Tratamiento de la Obesidad Infantojuvenil. Guías de Práctica Clínica en el SNS. Ministerio de Sanidad y Política Social, 2009.
9. Hernández M, Castellet J, Narvaiza JL, Rincón JM, Ruiz I, Sánchez E, et al. Curvas y tablas de crecimiento. Instituto de Investigación sobre Crecimiento y Desarrollo. Fundación Faustino Orbegozo. Madrid: Editorial Garsi; 1988.
10. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents -an IDF consensus report. Ped Diabetes. 2007;8:299-306
11. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist cincumference percentiles in nationally samples of African- American. European-American, and Mexican-American children and adolescents. J Pediatr. 2004;145:439-44
12. Lawrence JM, Mayer-Davis EJ, Reynolds K, Beyer J, Pettitt DJ, DAgostino Jr RB, et al. Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2:S123-32
13. Liu LL, Lawrence JM, Davis C, Liese AD, Pettitt DJ, Pihoker C, et al. Prevalence of overweight and obesity in youth with Diabetes in USA: the SEARCH for Diabetes in Youth Study. Pediatr Diabetes. 2010;11:4-11
14. Sandhu N, Witmans MB, Lemay JF, Crawford S, Jadavji N, Pacaud D. Prevalence of overweight and obesity in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2008;21:631-40
15. Van Vliet M, Van der Heyden JC, Diamant M, Von Rosenstiel IA, Schildhelm RK, Aanstoot HJ, et al. Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr. 2010;156:923-9
16. Shenoy S, Waldron S, Cody D, Swift PGF. Ethnic group differences in overweight and obese children with type 1 diabetes mellitus. Arch Dis Child. 2004;89:1076-7
17. Ferrante E, Pitzalis G, Vania A, De Angelis P, Guidi R, Fontana L, et al. Nutritional status obesity and metabolic control in children with type 1 diabetes mellitus. Minerva Pediatr. 1999;51:39-46
18. Luczynski W, Szypowska A, G'owinska-Olszewska B, Bossowski A. Overweight, obesity and features of metabolic syndrome in children with diabetes treated with insulin pump therapy. Eur J Pediatr. 2011;170:891-8
19. Luczynski W, Szypowska A, Bossowski A, Ramotowska A, Recko P, Rembinska M, et al. Overweight, obesity and metabolic syndrome in children with type 1 diabetes melllitus. Pediatr Endocrinol Diabetes Metab. 2010;16:83-8
20. Serra L, Ribas L, Aranceta J, Pérez C, Saavedra P, Peña L. Obesidad infantil y juvenil en España. Resultados del estudio enKid (1998-2000). Med Clin (Barc). 2003;121:725-32
21. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in The Diabetes Control and Complications Trial. Diabetes Care. 2001;24: 1711-21
22. Dailey G, Admane K, Mercier F, Owens D. Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir. Diabetes Technol Ther. 2010;12:1019-27
23. Zachariah S, Sheldon B, Shojaee-Moradie F, Jackson NC, Backhome K, Johnsen S, et al. Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes. Diabetes Care. 2011;34:1487-91
24. Szadkowska A, Pietrzak I, Szlawska J, Kozera A, Gadzicka A, Mynarski W. Abdominal obesity, metabolic syndrome in type 1 diabetic children and adolescents. Pediatr Endocrinol Diabetes Metab. 2009;15:233-9
25. Rodrigues TC, Canani LH, Gross JL. Metabolic syndrome, insulin resistance and cardiovascular disease in type 1 diabetes mellitus. Arq Bras Cardiol. 2010;94:125-30
26. Hirschler V, Aranda C, Calcagno ML, Maccalini G, Jadzinsky M. Can waist circumference identify children with the metabolic syndrome? Arch Pediatr Adolesc Med. 2005;159:740-4
27. Kabadi UM, Vora A, Kabadi M. Hyperinsulinemia and central adiposity. Diabetes Care. 2000;23:1024-5
28. Metascreen Writing Committee. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes. Diabetes Care. 2006;29:2701-7
29. Kelly AS, Jacobs Jr DR, Sinaiko AR, Moran A, Steffen LM, Steinberger J. Relation of circulating oxidized LDL to obesity and insulin resistance in children. Pediatr Diabetes. 2010;11:552-5
30. Muchacka-Bianga M, Deja G, Jarosz-Chobot P, Malecka-Tendera E, Kalina M, Grychtol M. Evaluation of selected risk factors of atherosclerosis in children with type 1diabetes mellitus and hypercholesterolemia. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12:25-30
31. Maahs DM, Hokanson JE, Wang H, Kinney GL, Snell-Bergeon JK, East A, et al. Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance. Diabetes. 2010;59:1771-9
32. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Graham Leslie RD. HbA1c levels are genetically determined even in type 1 diabetes. Diabetes. 2001;50:2858-63
33. Buyukinan M, Ozen S, Kokkun S, Saz EU. The relation of vitamin D deficiency with puberty and insulin resistance in obese children and adolescents. J Pediatr Endocrinol Metab. 2012;25:83-7
34. Ozgen IT, Tascilar ME, Bilir P, Boyraz M, Guncikan MN, Akay C, et al. Oxidative stress in obese children and its relation with insulin resistance. J Pediatr Endocrinol Metab. 2012;25:261-6
35. Chu SH, Park JH, Lee MK, Jekal Y, Ahn KY, Chung JY, et al. The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention. Clin Chim Acta. 2012;413:1430-7
36. Kyrgios I, Galli-Tsinopoulou A, Stylianou C, Papakonstantinou E, Arvanitidou M, Haidich AB. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children. Metabolism. 2012;61:562-8
37. McCormack SE, Shaham O, McCarthy MA, Deik AA, Wang TJ, Gerszten RE, et al. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes. 2012, http://dx.doi.org/10.1111/j.2047-6310.2012.00087.x.
38. Magkos F, Su X, Bradley D, Fabbrini E, Conte C, Eagon JC, et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology. 2012;142:1444-6
39. Madeira IR, Carvalho CN, Gazolla FM, Pinto LW, Borges MA, Bordallo MA. Impact of obesity on metabolic syndrome components and adipokines in prepubertal children. J Pediatr. 2009;85:261-8
40. Olza J, Gil-Campos M, Leis R, Bueno G, Aguilera CM, Valle M, et al. Presence of the metabolic syndrome in obese children at prepubertal age. Ann Nutr Metab. 2011;58:343-50